PRAME and melanoma: The differential expression of 35 genes as described by Izraely et al., including the levels of cysteine-rich protein 61 (CYR61) and of preferentially expressed antigen in melanoma (PRAME), are suggested to control the ability of disseminated melanoma cells to respond to microenvironment-derived signals in the brain [60].